Does trazodone have a role in palliating symptoms?
- PMID: 17131134
- DOI: 10.1007/s00520-006-0111-0
Does trazodone have a role in palliating symptoms?
Abstract
Introduction: Trazodone is a unique antidepressant, which blocks the postsynaptic serotonin (5-HT) receptors, 5-HT(2A) and 5-HT(2C), and weakly inhibits presynaptic 5-HT transporters.
Discussion: Trazodone is well-absorbed by the mouth and is metabolized by three cytochromes: CYP1A2, CYP2D6, and CYP3A4. Clinical benefits include reduced insomnia in those depressed and/or on antidepressants. Pain may be relieved by mechanisms similar to venlafaxine. Delirium unresponsive to neuroleptics has been reported to respond to trazodone. Drug interactions are a risk due to cytochrome metabolism.
Conclusion: Trazodone has a unique pharmacology, which may be an advantage in palliating symptoms; however, little evidence is available through cohort or randomized trials to give guidance to its use.
Similar articles
-
[Serotonin neurotrasmission and treatment options for depression].Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(11):174-177. doi: 10.17116/jnevro2017117111174-177. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 29265105 Review. Russian.
-
[Trazodone--its multifunctional mechanism of action and clinical use].Neuropsychopharmacol Hung. 2010 Dec;12(4):477-82. Neuropsychopharmacol Hung. 2010. PMID: 21220793 Review. Hungarian.
-
A review of the evidence for the efficacy and safety of trazodone in insomnia.J Clin Psychiatry. 2005 Apr;66(4):469-76. doi: 10.4088/jcp.v66n0409. J Clin Psychiatry. 2005. PMID: 15816789 Review.
-
Clinical guidance for the use of trazodone in major depressive disorder and concomitant conditions: pharmacology and clinical practice.Riv Psichiatr. 2019 Jul-Aug;54(4):137-149. doi: 10.1708/3202.31796. Riv Psichiatr. 2019. PMID: 31379379 Review.
-
Trazodone is only slightly faster than fluoxetine in relieving insomnia in adolescents with depressive disorders.J Child Adolesc Psychopharmacol. 1997 Summer;7(2):97-107. doi: 10.1089/cap.1997.7.97. J Child Adolesc Psychopharmacol. 1997. PMID: 9334895
Cited by
-
Antidepressants appear safe in patients with carcinoid tumor: Results of a retrospective review.Eur J Surg Oncol. 2018 Jun;44(6):744-749. doi: 10.1016/j.ejso.2018.03.010. Epub 2018 Mar 21. Eur J Surg Oncol. 2018. PMID: 29622373 Free PMC article.
-
Pharmacological management of depression in patients with cancer: practical considerations.Drugs. 2013 Jul;73(11):1131-45. doi: 10.1007/s40265-013-0090-7. Drugs. 2013. PMID: 23839658 Review.
-
Jitteriness/anxiety syndrome caused by coadministration of celecoxib, a selective COX-2 inhibitor, with escitalopram and trazodone in a patient with depression and spondylolisthesis.Neuropsychopharmacol Rep. 2023 Jun;43(2):264-266. doi: 10.1002/npr2.12325. Epub 2023 Feb 27. Neuropsychopharmacol Rep. 2023. PMID: 36847164 Free PMC article.
-
Is depression an appropriate response to having cancer? A discussion of diagnostic criteria and treatment decisions.Prim Care Companion J Clin Psychiatry. 2007;9(5):382-7. doi: 10.4088/pcc.v09n0508. Prim Care Companion J Clin Psychiatry. 2007. PMID: 17998958 Free PMC article. No abstract available.
-
Precision Medicine into Clinical Practice: A Web-Based Tool Enables Real-Time Pharmacogenetic Assessment of Tailored Treatments in Psychiatric Disorders.J Pers Med. 2021 Aug 27;11(9):851. doi: 10.3390/jpm11090851. J Pers Med. 2021. PMID: 34575628 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical